buprenorphine

FDA advisors recommend 2 opioid use disorder drugsTwo opioid use disorder drugs have been recommended for approval by FDA committees.
FDA Plans to Expand Access to Certain OpioidsCommissioner Scott Gottlieb makes a departure from previous policy.
Two opioid use disorder drug developments to watchNew physician-administered therapies on the horizon may help rein in the opioid epidemic.
FDA alters stance on opioid addiction drugs
FDA alters stance on opioid addiction drugsFDA is advising that these 2 opioid addiction medications should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system.
Seven things to know about Express Scripts’ plan to limit opioidsAs President Trump declares the opioid epidemic “a national emergency,” a new opioid management program from Express Scripts will limit the number and strength of opioid drugs to first-time patients.
Only 1 in 4 Opioid-Addicted Youth Receive Medication
Only 1 in 4 Opioid-Addicted Youth Receive MedicationYounger people, females, black or Hispanic less likely to have medication.
Fourteen things Trump needs to know about opioidsAs President Trump promises fight the opioid epidemic, here are 14 things experts want him to know.
Opinion: Substance use disorder privacy law limits both payers, prescribersTwo University of Massachusetts Medical School pharmacists make the case to reform or align 42 CFR Part 2 with HIPAA to better serve patients with substance use disorder.
Prescribing practices that increase risk of opioid overdoseTwo studies, one from Prime Therapeutics and Stanford, reveal an alarming increase in overdose with concurrent use of opioids and benzodiazepines. Here’s how managed care can help.
More resources needed for medication-assisted treatmentInclude medication-assisted treatment high on the list of clinical tools used to treat opioid addiction.